NanoViricides (NYSE-A:NNVC) said it has entered into a securities purchase agreement with a single institutional investor for gross proceeds of...
FTSE 100 down 69 points at 10,201 UK gilts near recent highs amidst possible Starmer exit Intertek received higher offer from private equity suitor...
Affirm (NASDAQ:AFRM) has been awarded a higher price target from Bank of America analysts following what the firm described as a strong fiscal third quarter...
Shares in Novo Nordisk (NYSE:NVO) drew a cautious reception from Citi following first-quarter results that beat consensus expectations, with the bank...
NanoViricides (NYSE-A:NNVC) is pointing to its lead drug candidate NV-387 as a potential solution to a critical gap in infectious disease preparedness, as a deadly hantavirus outbreak aboard a cruise
SHELTON, CT / ACCESS Newswire / May 11, 2026 / NanoViricides, Inc. (NYSE American:NNVC) (the "Company"), a clinical stage leader developing antiviral drugs that viruses cannot escape, emphasizes the c
Shelton, Connecticut--(Newsfile Corp. - May 6, 2026) - NanoViricides, Inc. (NYSE American: NNVC), today announced its participation in the D. Boral Capital Global Conference, taking place May 7, 2026,

NanoViricides to attend D Boral Capital Conference

12:09pm, Wednesday, 06'th May 2026
NanoViricides (NYSE-A:NNVC) will participate in the D. Boral Capital Global Conference on May 7, 2026, at The Plaza Hotel in New York City. President and...
NanoViricides (NYSE-A:NNVC) said on Monday its broad-spectrum antiviral drug NV-387 has been granted Orphan Drug Designation (ODD) by the US Food and Drug Administration, a regulatory milestone the c
SHELTON, CT / ACCESS Newswire / May 4, 2026 / NanoViricides, Inc., a publicly traded company (NYSE American:NNVC) (the "Company"), and a clinical stage, leading global pioneer in the development of br
The Coca-Cola Company (NYSE:KO) will report its first quarter earnings next week, with analysts at UBS expecting a steady performance from the drinks giant,...
NanoViricides (NYSE-A:NNVC) said on Tuesday its antiviral drug candidate NV-387 could help address rising measles cases globally, citing recent outbreaks and unmet treatment needs. The company pointed
SHELTON, CT / ACCESS Newswire / April 21, 2026 / NanoViricides, Inc., a publicly traded company (NYSE American:NNVC) (the "Company"), and a clinical stage, leading global pioneer in the development of
Amazon.com Inc (NASDAQ:AMZN) has announced a $5 billion investment in AI company Anthropic, alongside plans for up to an additional $20 billion in future...
4.15pm: In the green Optimism that a peace deal will soon be reached between the US and Iran and the kickoff of earnings season boosted Wall Street on...
Click to get the best stock tips daily for free!

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE